BOI Bank Irel13.375

RNS Number:7947C
Biotrace International PLC
11 May 2006



This replaces RNS statement 7854C issued at 7am 11 May 2006



For Immediate Release                                       11 May 2006



                           BIOTRACE INTERNATIONAL PLC

                   ("Biotrace", "the Company" or "the Group")


                                 AGM Statement



Biotrace International Plc, a leading manufacturer of industrial microbiology
products, will hold its Annual General Meeting today in Bridgend at 10:30am.



Mr Terry Clements, Chairman of Biotrace will read the following statement with
regard to current trading to those present at the meeting.

"Good progress was made in 2005 as the Group continued to consolidate its
position as a leading company in the industrial microbiology market. We have
made a positive start to 2006 with the contribution of MicroSafe, which was
acquired in September last year, adding significantly to the Group revenues.
Although it is early in the year we are also encouraged by the progress made in
growing our underlying sales. Other major initiatives announced in the first
quarter of 2006 included the disposal of Ruskinn Life Sciences and the sale of
the Group's HQ property in Bridgend. These transactions combined raised
approximately #1.7 million in cash for the Group and crystallised a gain of
approximately #0.5 million.


At the beginning of 2006 we signed a global agreement with Pall Corporation to
expand sales of air monitoring products to the Pharmaceutical market. This
collaboration is proceeding well and is enhancing our presence with the major
pharmaceutical companies and accelerating the sales of Ascotec products. In
March we acquired the remaining shares of Target Diagnostica srl in Italy
completing our distribution organisation for the Italian market.


Separately this morning we have announced that Biotrace has been awarded a
significant new defence contract by NATO's Maintenance and Supply Agency worth
#1.2 million, which will add to 2006 revenues.


Overall the Company is performing in line with our expectations and we remain
confident about the Group's future prospects."





                                    - ENDS -





For further information, please contact:
Biotrace International Plc
Ian Johnson, Chief Executive Officer                Tel : +44 (0) 1656 641 400

Peter Morgan, Finance Director

Buchanan Communications
Tim Anderson / James Strong                         Tel: +44 (0)20 7466 5000


Notes to editors:

Biotrace International Plc is a leading manufacturer and supplier of industrial
microbiology products. The Company is organised into three business segments:
Food & Environmental, Pharmaceutical, Personal Care & Cosmetics and Defence. The
Group's proprietary technologies are used by most of the world's leading food
and beverage manufacturers who rely on Biotrace products as an essential part of
their quality control procedures. Other industrial customers include
pharmaceutical and personal care product/cosmetics manufacturers together with
environmental/industrial process water clients. The Defence segment provides
systems and consumables for the rapid detection of biological weapons for
military and homeland security organisations.


Formed in 1988 and floated on the London Stock Exchange in 1993, Biotrace had
total revenues of over #29 million in 2005. The Company is headquartered in
Bridgend, UK with manufacturing and sales operations worldwide. Visit Biotrace
at www.biotrace.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMGIGDUGGBGGLB

Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Bank Irel13.375 (LSE:BOI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024